Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

The plasma biomarker soluble SIGLEC-1 is associated with the type I interferon transcriptional signature, ethnic background and renal disease in systemic lupus erythematosus.

Oliveira JJ, Karrar S, Rainbow DB, Pinder CL, Clarke P, Rubio García A, Al-Assar O, Burling K, Morris S, Stratton R, Vyse TJ, Wicker LS, Todd JA, Ferreira RC.

Arthritis Res Ther. 2018 Jul 27;20(1):152. doi: 10.1186/s13075-018-1649-1.

2.

Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus.

Biesen R, Demir C, Barkhudarova F, Grün JR, Steinbrich-Zöllner M, Backhaus M, Häupl T, Rudwaleit M, Riemekasten G, Radbruch A, Hiepe F, Burmester GR, Grützkau A.

Arthritis Rheum. 2008 Apr;58(4):1136-45. doi: 10.1002/art.23404.

3.

Monocyte Siglec-14 expression is upregulated in patients with systemic lupus erythematosus and correlates with lupus disease activity.

Thornhill SI, Mak A, Lee B, Lee HY, Poidinger M, Connolly JE, Fairhurst AM.

Rheumatology (Oxford). 2017 Jun 1;56(6):1025-1030. doi: 10.1093/rheumatology/kew498.

4.

IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus.

Rose T, Grützkau A, Hirseland H, Huscher D, Dähnrich C, Dzionek A, Ozimkowski T, Schlumberger W, Enghard P, Radbruch A, Riemekasten G, Burmester GR, Hiepe F, Biesen R.

Ann Rheum Dis. 2013 Oct;72(10):1639-45. doi: 10.1136/annrheumdis-2012-201586. Epub 2012 Oct 31.

PMID:
23117242
5.

Soluble Siglec-9 suppresses arthritis in a collagen-induced arthritis mouse model and inhibits M1 activation of RAW264.7 macrophages.

Matsumoto T, Takahashi N, Kojima T, Yoshioka Y, Ishikawa J, Furukawa K, Ono K, Sawada M, Ishiguro N, Yamamoto A.

Arthritis Res Ther. 2016 Jun 7;18(1):133. doi: 10.1186/s13075-016-1035-9.

6.

Plasma levels of galectin-3-binding protein reflect type I interferon activity and are increased in patients with systemic lupus erythematosus.

Nielsen CT, Lood C, Ostergaard O, Iversen LV, Voss A, Bengtsson A, Jacobsen S, Heegaard NH.

Lupus Sci Med. 2014 Nov 19;1(1):e000026. doi: 10.1136/lupus-2014-000026. eCollection 2014.

7.

Soluble Siglec-5 associates to PSGL-1 and displays anti-inflammatory activity.

Pepin M, Mezouar S, Pegon J, Muczynski V, Adam F, Bianchini EP, Bazaa A, Proulle V, Rupin A, Paysant J, Panicot-Dubois L, Christophe OD, Dubois C, Lenting PJ, Denis CV.

Sci Rep. 2016 Nov 28;6:37953. doi: 10.1038/srep37953.

8.

A soluble form of Siglec-9 provides a resistance against Group B Streptococcus (GBS) infection in transgenic mice.

Saito M, Yamamoto S, Ozaki K, Tomioka Y, Suyama H, Morimatsu M, Nishijima KI, Yoshida SI, Ono E.

Microb Pathog. 2016 Oct;99:106-110. doi: 10.1016/j.micpath.2016.08.014. Epub 2016 Aug 17.

PMID:
27544323
9.

A soluble form of Siglec-9 provides an antitumor benefit against mammary tumor cells expressing MUC1 in transgenic mice.

Tomioka Y, Morimatsu M, Nishijima K, Usui T, Yamamoto S, Suyama H, Ozaki K, Ito T, Ono E.

Biochem Biophys Res Commun. 2014 Jul 18;450(1):532-7. doi: 10.1016/j.bbrc.2014.06.009. Epub 2014 Jun 9.

PMID:
24924635
10.

Siglec-9 is upregulated in rheumatoid arthritis and suppresses collagen-induced arthritis through reciprocal regulation of Th17-/Treg-cell differentiation.

Wang X, Liu D, Ning Y, Liu J, Wang X, Tu R, Shen H, Chen Q, Xiong Y.

Scand J Immunol. 2017 Jun;85(6):433-440. doi: 10.1111/sji.12543.

11.

A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.

York MR, Nagai T, Mangini AJ, Lemaire R, van Seventer JM, Lafyatis R.

Arthritis Rheum. 2007 Mar;56(3):1010-20. Erratum in: Arthritis Rheum. 2007 May;56(5):1675.

12.

Increased expression of Siglec-1 on peripheral blood monocytes and its role in mononuclear cell reactivity to autoantigen in rheumatoid arthritis.

Xiong YS, Cheng Y, Lin QS, Wu AL, Yu J, Li C, Sun Y, Zhong RQ, Wu LJ.

Rheumatology (Oxford). 2014 Feb;53(2):250-9. doi: 10.1093/rheumatology/ket342. Epub 2013 Nov 5.

PMID:
24196391
13.

Increased expression of Toll-like receptors (TLRs) 7 and 9 and other cytokines in systemic lupus erythematosus (SLE) patients: ethnic differences and potential new targets for therapeutic drugs.

Lyn-Cook BD, Xie C, Oates J, Treadwell E, Word B, Hammons G, Wiley K.

Mol Immunol. 2014 Sep;61(1):38-43. doi: 10.1016/j.molimm.2014.05.001. Epub 2014 May 24.

PMID:
24865418
14.

Sialic acid-binding Ig-like lectin-7 interacts with HIV-1 gp120 and facilitates infection of CD4pos T cells and macrophages.

Varchetta S, Lusso P, Hudspeth K, Mikulak J, Mele D, Paolucci S, Cimbro R, Malnati M, Riva A, Maserati R, Mondelli MU, Mavilio D.

Retrovirology. 2013 Dec 13;10:154. doi: 10.1186/1742-4690-10-154.

15.

Monocyte surface expression of Fcgamma receptor RI (CD64), a biomarker reflecting type-I interferon levels in systemic lupus erythematosus.

Li Y, Lee PY, Kellner ES, Paulus M, Switanek J, Xu Y, Zhuang H, Sobel ES, Segal MS, Satoh M, Reeves WH.

Arthritis Res Ther. 2010;12(3):R90. doi: 10.1186/ar3017. Epub 2010 May 18.

16.

IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus.

Niewold TB, Kelly JA, Kariuki SN, Franek BS, Kumar AA, Kaufman KM, Thomas K, Walker D, Kamp S, Frost JM, Wong AK, Merrill JT, Alarcón-Riquelme ME, Tikly M, Ramsey-Goldman R, Reveille JD, Petri MA, Edberg JC, Kimberly RP, Alarcón GS, Kamen DL, Gilkeson GS, Vyse TJ, James JA, Gaffney PM, Moser KL, Crow MK, Harley JB.

Ann Rheum Dis. 2012 Mar;71(3):463-8. doi: 10.1136/annrheumdis-2011-200463. Epub 2011 Nov 16.

17.

Siglec-1-positive plasmacytoid dendritic cells (pDCs) in human peripheral blood: A semi-mature and myeloid-like subset imbalanced during protective and autoimmune responses.

Wilhelm TR, Taddeo A, Winter O, Schulz AR, Mälzer JN, Domingo C, Biesen R, Alexander T, Thiel A, Radbruch A, Hiepe F, Gerl V.

Clin Immunol. 2016 Feb;163:42-51. doi: 10.1016/j.clim.2015.12.001. Epub 2015 Dec 7.

PMID:
26674280
18.

Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.

Enocsson H, Wetterö J, Skogh T, Sjöwall C.

Transl Res. 2013 Nov;162(5):287-96. doi: 10.1016/j.trsl.2013.07.003. Epub 2013 Aug 1.

PMID:
23916811
19.

Cell-specific type I IFN signatures in autoimmunity and viral infection: what makes the difference?

Kyogoku C, Smiljanovic B, Grün JR, Biesen R, Schulte-Wrede U, Häupl T, Hiepe F, Alexander T, Radbruch A, Grützkau A.

PLoS One. 2013 Dec 31;8(12):e83776. doi: 10.1371/journal.pone.0083776. eCollection 2013.

20.

Increased expression of the type I interferon-inducible gene, lymphocyte antigen 6 complex locus E, in peripheral blood cells is predictive of lupus activity in a large cohort of Chinese lupus patients.

Tang J, Gu Y, Zhang M, Ye S, Chen X, Guo Q, Qian J, Bao C, Chen S, Shen N.

Lupus. 2008 Sep;17(9):805-13. doi: 10.1177/0961203308089694.

PMID:
18755862

Supplemental Content

Support Center